Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

PLOIDYNET · The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy

FP7Status: CLOSED1 October 201330 September 2017EU funding €3,017,790

Aneuploidy, an abnormal number of chromosomes, is a hallmark of cancer cells, affecting the majority of all human tumours. Aneuploidy arises when errors occur during mitosis, as the duplicated chromosomes are distributed between the two new daughter cells. Paradoxically, aneuploidy appears to have detrimental consequences for the physiology of untransformed cells in vitro, inhibiting rather than stimulating proliferation. This suggests that cancer cells have acquired mutations that help them cope with aneuploidy. Although it is clear that aneuploidy can contribute to cancer, the molecular consequences of aneuploidy remain elusive, as does how aneuploidy contributes to malignant transformation. The scientific aim of this network is to determine and compare the molecular consequences of different levels of aneuploidy, both in vivo and in vitro. Our network will train 9 Early Stage Career and 2 Experienced researchers in the aneuploidy field. To this aim, we are combining the expertise of labs that study the causes of aneuploidy with labs that induce aneuploidy in model organisms and study its consequences and also with labs that focus on the development of therapeutics that selectively kill aneuploid cell progeny. Our network is comprised of 11 full participants in 4 member states and 1 associated country and one associated partner, and includes 3 commercial enterprises. Within this network, we will provide technical training through research projects, but also through workshops and dedicated courses organized by the participants of this network. A significant part of the training will be provided by the industrial partners. Participating investigators and trainees will meet at a yearly conference to exchange and discuss results. Trainees will thus become experts in the field of aneuploidy while rapidly building up a scientific network for themselves, putting them in an excellent position to become future leaders in this field.

Consortium · 14 organisations

coordinator

STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS

NL · €329,920

participant

CANCER RESEARCH UK LBG

UK · €53,009

participant

THE UNIVERSITY OF MANCHESTER

UK · €296,057

participant

KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW

NL · €154,078

participant

EUROPEAN MOLECULAR BIOLOGY LABORATORY

DE · €67,186

participant

UNIVERSITAT BASEL

CH · €272,516

participant

MILTENYI BIOTEC GMBH

DE · €205,555

participant

ACADEMISCH ZIEKENHUIS GRONINGEN

NL · €376,758

participant

NETHERLANDS TRANSLATIONAL RESEARCHCENTER BV

NL · €219,979

participant

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

DE · €181,639

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €91,033

participant

THE FRANCIS CRICK INSTITUTE LIMITED

UK · €240,934

participant

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

DE · €233,069

participant

THE UNIVERSITY OF EDINBURGH

UK · €296,057

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.